NRAS and melanoma: In summary, Echevarría‐Vargas et al (2018) have not only developed a new therapeutic strategy for treating NRAS‐mutant and immune therapy‐resistant melanoma, but also elucidated the molecular mechanism of NRAS mutation and immune therapy resistance in melanoma.